Experimental Information |
|
Enzymatic Activity |
Molecule Id | EGIN0001894 |
PMID | 17416531 |
Assay Used | Enzyme assay at 1µM of ATP |
Experimently Validated | Yes |
EGFR (IC50) | 166.7 nM |
HER2 (IC50) | - |
HER4 (IC50) | - |
Mutant L858R (IC50) | - |
Mutant T790M (IC50) | - |
Double Mutant (IC50) | - |
Average ERBB2 and ERBB1 (IC50) | - |
Inhibition EGFR (%) | - |
Inhibitory Concentration | - |
Inhibition HER2 (%) | - |
Inhibitory Concentration | - |
Ki (EGFR) | - |
Ki (HER2) | - |
Ki (HER4) | - |
Kd (EGFR) | - |
Kd (L858R) | - |
Kd (T790M) | - |
Kd (L858R/T790M) | - |
Kd (Other mutation) | - |
Note | The paper describes the Dual Quinazoline-based irreversible kinase inhibitors EGFR and VEGFR-2. |
Extra | 894.3nM(IC50 at1 mM ATP) |
| |